LDR brachytherapy of "low risk" prostate cancer: Update of the 5-year experience in 118 patients

被引：0
|
作者：
Block, T.
Zimmermann, F.
Czempiel, H.
机构：
[1] Urol Praxis, Vaterstetten, Germany
[2] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2007年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] ACTIVE SURVEILLANCE IN LOW-RISK PROSTATE CANCER PATIENTS: A 5-YEAR SINGLE INSTITUTION EXPERIENCE
    Giganti, Maria Olga
    Rancati, Tiziana
    Nicolai, Nicola
    Villa, Sergio
    Donegani, Simona
    Magnani, Tiziana
    Bedini, Nice
    Salvioni, Roberto
    Valdagni, Riccardo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1540 - 1541
  • [2] Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer
    Zelefsky, M
    Yamada, J
    Fuks, Z
    Chan, H
    Cohen, G
    Zaider, M
    Leibel, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [3] Similar 5-year clinical outcome for high dose rate (HDR) and low dose rate (LDR) brachytherapy (BT) for early prostate cancer
    Ghilezan, M
    Vargas, C
    Gustafson, G
    Boike, T
    Chao, K
    Kestin, L
    Grills, I
    Sebastian, E
    Martinez, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S37 - S37
  • [4] Results of LDR - Brachytherapy for localized Prostate Cancer with Low-risk Profile
    He, H.
    Ubrich, F.
    Elvermann, A.
    Olbert, P. J.
    Hegele, A.
    Engenhart-Cabillic, R.
    Strassmann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 113 - 113
  • [5] Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer
    Pickles, Tom
    Morris, W. James
    Kattan, Michael W.
    Yu, Changhong
    Keyes, Mira
    BRACHYTHERAPY, 2011, 10 (01) : 9 - 14
  • [6] I-125 LDR Brachytherapy in Patients with Low-risk Prostate Cancer - a retrospective Analysis of Patients
    Fels, F.
    Okonkwo, E.
    Schadt, T.
    Laschke, S.
    Loevey, G.
    Lansing, D.
    Grossmann, J. G.
    Freund, U.
    Steurer, R.
    Momm, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S87 - S87
  • [7] Biochemical failure in low and intermediate risk prostate cancer patients after LDR Brachytherapy appear similar
    Taggar, A.
    Martell, K.
    Sia, M.
    Angyalfi, S.
    Husain, S.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S62 - S62
  • [8] Interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer
    Machtens, S
    Karstens, JH
    Baumann, R
    Jonas, U
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (06) : 514 - 521
  • [9] Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience
    Fossa, Sophie D.
    Nilssen, Yngvar
    Kvale, Rune
    Hernes, Eivor
    Axcrona, Karel
    Moller, Bjorn
    UROLOGY, 2014, 83 (01) : 146 - 152
  • [10] Low toxicity of focal low-dose-rate (LDR) brachytherapy for intermediate risk prostate cancer
    Harkin, Timothy
    Smyth, Lloyd
    Anderson, Elliot
    O'Sullivan, Richard
    Ryan, Andrew
    Lawrentschuk, Nathan
    Katz, Darren
    Grummet, Jeremy
    See, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 76 - 76
12345